According to Ironwood Pharmaceuticals 's latest financial reports the company's total debt is $0.71 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.71 B | 72.04% |
2022-12-31 | $0.41 B | -12.59% |
2021-12-31 | $0.47 B | 4.87% |
2020-12-31 | $0.45 B | 5.21% |
2019-12-31 | $0.43 B | 4.18% |
2018-12-31 | $0.41 B | 3.44% |
2017-12-31 | $0.40 B | 7.34% |
2016-12-31 | $0.37 B | -2.28% |
2015-12-31 | $0.38 B | 120.35% |
2014-12-31 | $0.17 B | -3.25% |
2013-12-31 | $0.17 B | 31349.03% |
2012-12-31 | $0.56 M | -13.13% |
2011-12-31 | $0.65 M | 11.02% |
2010-12-31 | $0.59 M | -70.76% |
2009-12-31 | $2.01 M | -4.86% |
2008-12-31 | $2.12 M | -28.42% |
2007-12-31 | $2.96 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
AstraZeneca AZN | $34.55 B | 4,728.67% | ๐ฌ๐ง UK |
Nektar Therapeutics
NKTR | $0.11 B | -83.54% | ๐บ๐ธ USA |